Metachronous Pancreatic Metastasis of Myxoid Liposarcoma Successfully Treated With Robotic Spleen‐Preserving Distal Pancreatectomy With Splenic Vessels Resections: A Case Report

TL;DR

A rare case of pancreatic metastasis from myxoid liposarcoma was successfully treated with a robotic spleen-preserving surgery.

Contribution

First reported case of metachronous pancreatic metastasis of myxoid liposarcoma treated with robotic spleen-preserving distal pancreatectomy.

Findings

Robotic surgery successfully removed a 6-cm pancreatic metastasis with no recurrence after 3 months.

The procedure preserved the spleen and used the Warshaw technique for vessel resection.

No distant metastases were detected, supporting curative resection for isolated cases.

Abstract

Pancreatic metastasis of myxoid liposarcoma (MLS) after primary resection is extremely rare. Herein, we present a case of metachronous pancreatic metastasis of MLS that was successfully treated with robotic spleen‐preserving distal pancreatectomy (SPDP) using the Warshaw technique. A 60‐year‐old woman underwent radical resection of a 25‐cm MLS in the right thigh after receiving neoadjuvant radiotherapy. The patient developed a 6‐cm solitary pancreatic metastasis of the MLS 2 years later. Because no other distant metastases were detected, robotic SPDP (Warshaw technique) was performed. The operative time was 140 min with minimal blood loss. Follow‐up at 3 months showed no recurrence. To our knowledge, this is the first report of a case of metachronous pancreatic metastasis of MLS successfully treated with robotic SPDP. Curative resection using minimally invasive surgery should be performed for solitary pancreatic metastases from MLS.

Figures